Maximum Strength Wart Remover with Salicylic Acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common warts and plantar warts. Common warts are characterized by a rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

Using the provided applicator, one drop of the medication should be carefully applied to each wart, ensuring that the wart is sufficiently covered. It is important to allow the application to dry completely before proceeding.

This procedure may be repeated once or twice daily as necessary, continuing until the wart is removed, for a maximum duration of 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

• Patients with diabetes or poor blood circulation, due to the increased risk of complications.

• Application on genital warts, warts located on the face, or mucous membranes is prohibited to avoid potential adverse effects.

• The product should not be applied to moles, birthmarks, or warts with hair growth, as these may indicate underlying conditions that require different management.

• Avoid use on irritated skin or any area that is infected or reddened, as this may exacerbate the condition or lead to further irritation.

Warnings and Precautions

For external use only. This product is flammable; it must be kept away from fire or flame to prevent ignition.

The use of this product is contraindicated in individuals with diabetes or those who exhibit poor blood circulation. It should not be applied to genital warts, warts located on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. Additionally, it is not recommended for use on irritated skin or any area that is infected or reddened.

Healthcare professionals should advise patients to discontinue use and consult a physician if discomfort persists.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought by contacting a Poison Control Center at 1-800-222-1222.

When using this product, it is essential to take precautions to ensure safety. If the product comes into contact with the eyes, it should be flushed with water for at least 15 minutes. Users should avoid inhaling vapors and ensure that the bottle is capped tightly after use. The product should be stored at room temperature, away from heat sources, to maintain its efficacy and safety.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated in individuals who are diabetic or have poor blood circulation. Additionally, the product should not be applied to genital warts, warts on the face or mucous membranes, moles, birthmarks, or warts with hair growing from them. It is also not recommended for use on irritated skin or any area that is infected or reddened.

During the use of this product, if it comes into contact with the eyes, it is advised to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors associated with the product.

If discomfort persists, patients are instructed to stop use and consult a healthcare professional. It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center (1-800-222-1222) is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Maximum Strength Wart Remover with Salicylic Acid (wart remover with salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no explicit statements regarding safety concerns, dosage modifications, or special precautions for use during pregnancy. Therefore, healthcare professionals should exercise caution when prescribing this product to women of childbearing potential. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Further research may be necessary to fully understand the implications of this product during pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects on lactation. Additionally, no data are provided concerning the excretion of this medication in breast milk or its potential effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed.

In the event that the product comes into contact with the eyes, patients should be instructed to flush the affected area with water for at least 15 minutes to minimize potential harm.

It is important to inform patients about the risks associated with inhaling vapors from the product and to encourage them to avoid such exposure.

Patients should be reminded to cap the bottle tightly after each use to prevent accidental spillage or exposure.

Additionally, healthcare providers should counsel patients on the proper storage of the product, emphasizing the need to keep it at room temperature and away from heat sources to maintain its efficacy and safety.

Storage and Handling

The product is supplied in a container that must be stored at a temperature range of 20°-25°C (68°-77°F). It is essential to close the container tightly after each use to prevent solidification. The top of the bottle should be wiped clean following each application to maintain hygiene and product integrity.

Care should be taken to avoid contact with surrounding skin during application. Additionally, the product should not come into contact with fabrics, floors, countertops, or other surfaces, as it may cause staining. It is also important to keep the product away from fire or flame.

The product should be discarded when signs of the wart no longer appear to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Maximum Strength Wart Remover with Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)